Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The human T cell leukaemia/lymphoma virus type I (HTLV-I) was isolated nearly 17 years ago from a patient who had what is now called adult T cell leukaemia/lymphoma. This aggressive condition responds poorly to chemotherapy, with a median survival of only a few months.1 HTLV-I is also unequivocally linked with tropical spastic paraparesis, a progressive, unremitting myelopathy for which there is no specific treatment. HTLV-I is transmitted through sexual intercourse (especially from men to women), breast feeding, sharing intravenous needles, and blood transfusion. Between 12.8% and 63.4% of people receiving blood infected with HTLV-I will seroconvert.2 3 Fresh blood products (those less than six days old) have a transmission efficiency of 80%.2
Transfusion services in Britain do not currently screen blood donors for HTLV-I. This policy is based on a low prevalence of HTLV-I among British blood donors (ranging from 1 in 19000 donors in North London
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?